BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Bacteroidota |
📓
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats. PeerJ (PeerJ ) Vol: 6 Issue Pages: e4446 Pub: 2018 Epub: 2018 Mar 1 Authors Zhang Q , Yu H , Xiao X , Hu L , Xin F , Yu X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Bacteroidota |
📓
Dietary Inulin Regulated Gut Microbiota and Improved Neonatal Health in a Pregnant Sow Model. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 716723 Pub: 2021 Epub: 2021 Aug 9 Authors Li H , Ma L , Zhang L , Liu N , Li Z , Zhang F , Liu X , Ma X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Bacteroidota |
📓
Effects of Dietary Ratio of Insoluble Fiber to Soluble Fiber on Reproductive Performance, Biochemical Parameters, and Fecal Microbial Composition of Gestating Sows. Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 15 Issue 13 Pages: Pub: 2025 Jun 23 Epub: 2025 Jun 23 Authors Wen X , Wu Q , Gao K , Yang X , Xiao H , Jiang Z , Wang L , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Bacteroidota |
📓
Synergetic responses of intestinal microbiota and epithelium to dietary inulin supplementation in pigs. European journal of nutrition (Eur J Nutr ) Vol: 60 Issue 2 Pages: 715-727 Pub: 2021 Mar Epub: 2020 May 20 Authors He J , Xie H , Chen D , Yu B , Huang Z , Mao X , Zheng P , Luo Y , Yu J , Luo J , Yan H , Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Bacteroidota |
📓
Inulin fiber dose-dependently modulates energy balance, glucose tolerance, gut microbiota, hormones and diet preference in high-fat-fed male rats. The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 59 Issue Pages: 142-152 Pub: 2018 Sep Epub: 2018 Jun 12 Authors Singh A , Zapata RC , Pezeshki A , Reidelberger RD , Chelikani PK , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
